Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 12:22:e9.
eCollection 2022.

Trends in Skin Melanoma Burden: Findings From the Global Burden of Disease Study

Affiliations

Trends in Skin Melanoma Burden: Findings From the Global Burden of Disease Study

Charalampos Siotos et al. Eplasty. .

Abstract

Background: Melanoma is the third most common skin cancer and the leading cause of skin cancer mortality. This study sought to investigate trends in melanoma incidence, mortality, and burden of disease.

Methods: The authors assessed the records of the Global Burden of Disease Study 2017 to extract information about the incidence, mortality, and disability adjusted life years (DALY) related to melanoma during 1990-2017 in the US and other countries based on their socio-demographic index (SDI).

Results: Melanoma incidence in the US increased 1.6 times, although the difference was not statistically significant. For patients over the age of 60, the incidence was significantly increased by 1.72 to 164.6 times. Mortality was relatively stable during the study period; however, it was increased for patients over 65 years of age (range: 1.03 to 70 times), although not statistically significant. Mortality-to-incidence ratio was decreased, but the difference was not statistically significant. For patients over 75 years of age, DALYs were statistically significantly increased by 1.34 to 1.71 times.

Conclusions: This study highlights differences in melanoma incidence and mortality from 1990-2017. Physicians involved in melanoma care should be aware of these changes in order to anticipate care needs.

Keywords: burden; global; incidence; melanoma; mortality.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Incidence of melanoma from 1990 to 2017 in US and other countries based on SDI. Incidence is expressed in cases per 100,000 age-standardized population.
FIGURE 2
FIGURE 2
M/I of melanoma from 1990 to 2017 in US and other countries based on SDI.
FIGURE 3
FIGURE 3
Disability adjusted life years (DALYs) of melanoma from 1990 to 2017 in US and other countries based on SDI.

Similar articles

Cited by

References

    1. Henley SJ, Ward EM, Scott S. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer. May 15 2020;126(10):2225-2249. - PMC - PubMed
    1. Watson M, Geller AC, Tucker MA, Guy GP Jr, Weinstock MA. Melanoma burden and recent trends among non-Hispanic whites aged 15-49 years, United States. Prev Med. Oct 2016;91:294-298. - PMC - PubMed
    1. Guy GP Jr., Thomas CC, Thompson T, Watson M, Massetti GM, Richardson LC. Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030. MMWR. Morb Mortl Wkly Rep. Jun 5 2015;64(21):591-596. - PMC - PubMed
    1. Karimkhani C, Green AC, Nijsten T. The global burden of melanoma: results from the Global Burden of Disease Study 2015. Br J Dermatol. Jul 2017;177(1):134-140. - PMC - PubMed
    1. Guy GP, Ekwueme DU. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. PharmacoEconomics. Oct 2011;29(10):863-874. - PubMed

LinkOut - more resources